Back
iShares Russell 1000 ETF Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
81
IWB
iShares Russell 1000 ETF
Last Price:
297.48
Seasonality Move:
1%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Buy
81
iShares Russell 1000 ETF (IWB)
is a Buy
Is iShares Russell 1000 ETF a Buy, Sell or Hold?
- The current iShares Russell 1000 ETF [IWB] share price is $298.69. The Score for IWB is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- IWB is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IWB Stock Price Chart
What is iShares Russell 1000 ETF's stock price today?
-
The iShares Russell 1000 ETF share price today is $298.69
The current trend is moderately bullish and IWB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
IWB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.87 | Buy |
Relative Strength Index (14 RSI): | 70.82 | Buy |
Chaikin Money Flow: | 296195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (289.64 - 297.28) | Buy |
Bollinger Bands (100): | (277.04 - 291.58) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.83 | Buy |
Relative Strength Index (14 RSI): | 90.67 | Buy |
Chaikin Money Flow: | -365678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.21 - 198.95) | Buy |
Bollinger Bands (100): | (137.63 - 173.99) | Buy |
IWB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 297.98 | Buy |
20-day SMA: | 294.41 | Buy |
50-day SMA: | 287.8 | Buy |
200-day SMA: | 266.51 | Buy |
8-day EMA: | 297.5 | Buy |
20-day EMA: | 294.97 | Buy |
50-day EMA: | 289.95 | Buy |
200-day EMA: | 270.94 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 198.72 | Buy |
20-day SMA: | 171.59 | Buy |
50-day SMA: | 157.67 | Buy |
200-day SMA: | 165.81 | Buy |
8-day EMA: | 210.85 | Buy |
20-day EMA: | 183.04 | Buy |
50-day EMA: | 165.87 | Buy |
200-day EMA: | 167.34 | Buy |
iShares Russell 1000 ETF Earnings Growth & IWB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
iShares Russell 1000 ETF Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |